---
title: 'Director, Patient Services Patient Strategy at Definium Therapeutics'
canonical: 'https://feeny.ai/job/director-patient-services-patient-strategy-definium-therapeutics-remote-2ht8ekq69e73'
type: 'job'
last_seen: '2026-09-22'
---

# Director, Patient Services Patient Strategy at Definium Therapeutics

- **Company:** Definium Therapeutics
- **Location:** Remote
- **Work type:** remote
- **Posted:** 2026-08-31
- **Last confirmed live:** 2026-09-22
- **Apply:** https://job-boards.greenhouse.io/definiumtherapeutics/jobs/6161261004

## Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

The Director, Patient Services Patient Strategy will own the development of and ensure the successful execution of the Patient Services strategy to drive the successful commercial launch of DT120, working closely with Regulatory, Marketing, Legal, and cross-functional commercial teams to align with corporate goals. This role will drive how Definium Patient Services supports patients across onboarding, treatment preparation, all aspects of REMS, and ongoing support, while ensuring all initiatives meet stringent regulatory standards (e.g., FDA). This role is responsible for the strategy creation and ensuring that Definium PS Case Management teams are set up for success as they engage with patients and external parties.

Responsibilities:

- Develop and execute patient support strategies to support the successful launch and commercialization of DT120
- Support development and implementation of potential REMS For DT120 via partnership with Compliance and other internal and external partners
- Design, continuously refine, and operationalize the end-to-end patient/ care partner journeys—from referral through long-term follow-up—ensuring a seamless and compliant  treatment experience
- Translate patient support strategy into operational workflows, business requirements, CRM functionality, reporting needs, and digital capabilities to enable scalable execution
- Identify opportunities to leverage AI-enabled capabilities, automation, and digital engagement to enhance patient experience, operational efficiency, and proactive patient support.
- Create external materials driving positive engagement with DT120 and Definium team members
- Create internal training materials ensuring that all patient facing teams have the required expertise on DT120, REMS, and Definium Patient Services
- Ensure Patient Services strategies support patients with ongoing REMS related education and compliance needs
- Utilize data and analytics to drive departmental, program, and patient success
- Manage team of direct reports driving both team culture and overall success
- Work across PS teams to implement patient journey
- Lead Patient Services launch readiness activities including SOP development, training, operational testing, governance, and cross-functional launch planning.
- Drive overly department culture as member of Patient Services Leadership Team
- Oversee the promotional review process (MLR/PRC) to ensure all patient-facing marketing materials are compliant with regulatory requirements
- Partner with Medical Affairs, Marketing, Sales, Market Access partners, and cross-functional commercial teams to align engagement strategies with broader business objectives
- Translate market insights into actionable strategies that strengthen engagement, differentiation, and launch readiness

## Qualifications

- Bachelor’s degree in Life Sciences, Marketing, Business, Communications, or related discipline; advanced degree preferred
- Minimum 10 years industry related experience required
- Minimum 5 years Patient Services experience required
- Significant understanding of PS compliance and legal guidelines required
- Understanding of internal and external material creation process (i.e., PRC)
- Experience designing patient support operating models required
- Experience with Patient Services CRM systems preferred
- Experience with REMS strategies, compliance, and support offerings preferred
- Skilled in cross-functional collaboration; intellectually curious, solutions-oriented, and effective at communicating and socializing strategic recommendations
- Launch experience in the U.S. pharmaceutical market required
- Experience in CNS / psychiatry, specialty pharmaceutical, or complex treatment categories preferred
- Experience with process design and workflow development
- Experience supporting highly regulated therapies (REMS or DEA Drug Scheduling equivalent).
- Ability to synthesize complex clinical, market, and customer data into actionable strategies
- Strong presentation skills and ability to influence senior, cross-functional, and agency stakeholders
- Ability to lead through ambiguity in a pre-commercial environment
- Ability to travel as required; average 10–20%, with higher travel during key launch periods

The starting base pay range for this position is $180,000-$235,000, with compensation determined based on several factors including skill set, years of experience, and geographic location.

Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:

- 100% paid health benefits including Medical, Dental and Vision for you and your dependents
- 401(k) program with company match and vesting after the turn of the first month after your start date
- Flexible time off
- Generous parental leave and some fun fringe perks!

## About Definium Therapeutics

## Company Overview
- **One-liner**: Definium Therapeutics is a clinical-stage biopharmaceutical company applying scientific rigor to psychedelic medicine to develop accessible treatments for psychiatric disorders.
- **Entity Type**: Public (NASDAQ: DFTX)
- **Headquarters**: Not specified in available sources; the company operates as a remote-first organization.
- **Founded**: 2019 (originally as MindMed)
- **Founders**: Not publicly available in provided sources.

## Core Business
- **Primary Industry**: Biotechnology / Psychiatric drug development (psychedelic medicine)
- **Target Customers**: Patients with major depressive disorder (MDD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), and autism spectrum disorder (ASD); also healthcare providers and payers.
- **Mission/Purpose**: “Unlock healing at scale” by harnessing the full therapeutic potential of psychedelic medicine through precise, evidence-based science.

## Products & Services
- **DT120 ODT (Lysergide/LSD D-Tartrate Oral Disintegrating Tablet)**: Investigational drug for GAD, MDD, and PTSD. Currently in four Phase 3 trials (Voyage, Panorama, Emerge, Ascend) and a fifth planned for PTSD. FDA Breakthrough Therapy Designation for GAD. No adjunctive psychotherapy required.
- **DT402 (R(-)-MDMA)**: R-enantiomer of MDMA selected for serotonergic properties with a potentially superior tolerability profile. In Phase 2a study for social communication challenges in autism spectrum disorder.

## Market Standing
- **Valuation/Market Cap**: Not publicly available (publicly listed on NASDAQ as DFTX as of 2026, but recent market cap not provided in search results).
- **Key Metric**: Pre-revenue clinical-stage company; total funding history not disclosed in available sources.
- **Notable Investors/Partners**: Not disclosed in provided sources.
- **Growth Signals**:
  - Five Phase 3 trials ongoing or planned for DT120 ODT.
  - FDA Breakthrough Therapy Designation for DT120 in GAD.
  - Phase 2a trial initiated for DT402 in ASD.
  - Full results from Phase 2b GAD trial published in JAMA (2025).
  - Strong intellectual property with issued patents covering formulation, manufacturing, and treatment.

## Competitive Advantages
- **Proprietary Formulations**: Pharmaceutically optimized ODT for LSD (DT120) and novel R-enantiomer of MDMA (DT402) with potential improved tolerability.
- **Scientific Rigor**: Standalone drug studies without psychotherapy, enabling clearer efficacy and safety data.
- **Regulatory Momentum**: FDA Breakthrough Therapy Designation and multiple IND clearances.
- **Experienced Management Team**: Proven track record in developing and commercializing CNS therapies.
- **Comprehensive IP Strategy**: Patents covering drug formulations, methods of manufacture, and treatment use.

## Strategic Focus
- **Late-Stage Pipeline Advancement**: Completing Phase 3 trials for GAD and MDD, initiating PTSD trial.
- **Pipeline Expansion**: Advancing DT402 for ASD and exploring additional neuropsychiatric indications.
- **Commercial Readiness**: Building infrastructure (hiring VP of Sales, Senior Director of Field VEOR, etc.) to support potential future launch.
- **Data Generation**: Generating high-quality evidence to support regulatory submissions and differentiation.

## Why Work Here
- **Remote-First Culture**: “You can live anywhere in the country you’re employed in” (remote-first workforce).
- **Comprehensive Benefits**: 100% paid medical, dental, vision for employees and dependents; FSA/HSA; life and disability insurance.
- **Wellness & Time Off**: Annual wellness allowance, flexible PTO, company-wide shutdowns for rest.
- **Family Support**: Paid parental leave for birthing and non-birthing parents, 2-week return-to-work transition.
- **Financial Wellness**: Competitive compensation, 401(k) with employer match, employee equity (new hire grants and refreshes), Employee Stock Purchase Plan (ESPP) with discount.
- **Mission-Driven Work**: Opportunity to contribute to groundbreaking treatments in psychedelic psychiatry with a science-driven, collaborative team.

## Sources
1. [definiumtx.com](https://definiumtx.com/) – Company overview and pipeline details
2. [definiumtx.com](https://definiumtx.com/story/) – Company history, leadership, and strategic milestones
3. [definiumtx.com](https://definiumtx.com/careers/) – Careers page with benefits and remote-first policy
4. [definiumtx.com](https://definiumtx.com/research-development/) – Research and development pipeline details
5. [linkedin.com](https://www.linkedin.com/company/definiumtherapeutics) – LinkedIn company page

## Other roles at Definium Therapeutics

- [Staff Accountant](https://feeny.ai/job/staff-accountant-definium-therapeutics-remote-crzmf7hrv4fn)
- [Director, Talent Acquisition Commercial](https://feeny.ai/job/director-talent-acquisition-commercial-definium-therapeutics-remote-6gnxe2cb0ac7)
- [Director, Supply and Distribution Quality](https://feeny.ai/job/director-supply-and-distribution-quality-definium-therapeutics-remote-6hf75zdnx5pq)
- [Director, Medical Communications](https://feeny.ai/job/director-medical-communications-definium-therapeutics-remote-35fwkadvgv4y)
- [Director, Patient Services Operations](https://feeny.ai/job/director-patient-services-operations-definium-therapeutics-raleigh-durham-north-b25ndrr3vznf) — Raleigh/durham North Carolina, United States
- [Director, Patient Services Site of Care Strategy](https://feeny.ai/job/director-patient-services-site-of-care-strategy-definium-therapeutics-remote-zmxjxzq1d1m1)
- [Director, Late Stage Clinical Development](https://feeny.ai/job/director-late-stage-clinical-development-definium-therapeutics-remote-z4qyxsz0r83k)
- [Contract Operations Specialist](https://feeny.ai/job/contract-operations-specialist-definium-therapeutics-remote-1hgqsggf6t08)
- [Sr Director, Commercial Finance](https://feeny.ai/job/sr-director-commercial-finance-definium-therapeutics-remote-rej1kjas72m6)
- [Assoc. Director, Regulatory Affairs Advertising and Promotion](https://feeny.ai/job/assoc-director-regulatory-affairs-advertising-and-promotion-definium-qywtveman5jg)